BNP PARIBAS FINANCIAL MARKETS - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$695,881
+104.9%
89,560
+155.3%
0.00%
Q2 2023$339,603
-44.5%
35,083
-37.2%
0.00%
-100.0%
Q1 2023$612,028
+331.1%
55,842
+69.9%
0.00%
Q4 2022$141,981
-100.0%
32,866
-49.0%
0.00%
-100.0%
Q3 2022$484,296,000
+58.9%
64,401
+112.4%
0.00%
Q2 2022$304,746,000
-56.3%
30,323
-46.2%
0.00%
-100.0%
Q1 2022$697,378,000
+29500.1%
56,331
+54590.3%
0.00%
Q4 2021$2,356,000
-94.1%
103
-94.3%
0.00%
Q3 2021$39,679,0001,7930.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders